Literature DB >> 3703493

Bietti's crystalline retinopathy.

M Yuzawa, Y Mae, M Matsui.   

Abstract

The authors reported a case of Bietti's crystalline retinopathy in 1981. In the present paper they report three additional cases studying the stages of this disease and the clinical findings at each stage. Conclusions obtained are as follows: This disease is a type of total RPE-choriocapillaris dystrophy, the process of which starts at the posterior pole. This disease can be divided into three stages, based on the clinical findings: Stage 1: RPE atrophy with uniform fine white crystalline deposits is observed at the macular area. Stage 2: RPE atrophy extends beyond the posterior pole. Choriocapillaris atrophy in addition to the RPE atrophy appears markedly at the posterior pole. Crystalline deposits in the lesion vary in shape and size and have a tendency to conflue. The number of crystalline deposits is less in the advanced atrophic areas of the RPE-choriocapillaris complex. Stage 3: RPE-choriocapillaris complex atrophy is observed throughout the fundus. The total number of crystalline deposits decreases because the crystalline deposits that disappear number more than those that appear in Stage 3. Crystalline deposits which are observed at the corneal limbus are possibly prominent in the advanced stage of atrophy of the RPE-choriocapillaris complex.

Entities:  

Mesh:

Year:  1986        PMID: 3703493     DOI: 10.3109/13816818609058037

Source DB:  PubMed          Journal:  Ophthalmic Paediatr Genet        ISSN: 0167-6784


  18 in total

Review 1.  The differential diagnosis of crystals in the retina.

Authors:  F Nadim; H Walid; J Adib
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Fine retinal crystalline deposits observed by confocal scanning laser ophthalmoscopic examination using infrared light.

Authors:  Y Yanagi; Y Tamaki; H Fukushima
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  Bietti's crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics.

Authors:  Audra Mei Yee Fong; Adrian Koh; Kelvin Lee; Chong Lye Ang
Journal:  Int Ophthalmol       Date:  2008-10-15       Impact factor: 2.031

4.  An atypical form of Bietti crystalline dystrophy.

Authors:  Settimio Rossi; Francesco Testa; Anren Li; Valentina Di Iorio; Jun Zhang; Carlo Gesualdo; Michele Della Corte; Chi-Chao Chan; J Fielding Hejtmancik; Francesca Simonelli
Journal:  Ophthalmic Genet       Date:  2011-03-08       Impact factor: 1.803

5.  [Generation and characterization of Cyp4v3 gene knockout mice].

Authors:  R X Jia; S W Jiang; L Zhao; L P Yang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

6.  Evolution of Cellular Inclusions in Bietti's Crystalline Dystrophy.

Authors:  Emiko Furusato; J Douglas Cameron; Chi-Chao Chan
Journal:  Ophthalmol Eye Dis       Date:  2010-03-09

7.  A novel mutation of CYP4V2 gene associated with Bietti crystalline dystrophy complicated by choroidal neovascularization.

Authors:  Xin-Yao Han; Lin-Qi Zhang; Ji-Yang Tang; Lyu-Zhen Huang; Ran Tang; Jin-Feng Qu
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

8.  Clinical and genetic features in Italian Bietti crystalline dystrophy patients.

Authors:  Settimio Rossi; Francesco Testa; Anren Li; Fulya Yaylacioğlu; Carlo Gesualdo; J Fielding Hejtmancik; Francesca Simonelli
Journal:  Br J Ophthalmol       Date:  2012-12-06       Impact factor: 4.638

9.  Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy.

Authors:  Houfa Yin; Chongfei Jin; Xiaoyun Fang; Qi Miao; Yingying Zhao; Zhiqing Chen; Zhaoan Su; Panpan Ye; Yao Wang; Jinfu Yin
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

10.  Expanding the Phenotypic and Genotypic Spectrum of Bietti Crystalline Dystrophy.

Authors:  Mariana Matioli da Palma; Fabiana Louise Motta; Mariana Vallim Salles; Caio Henrique Marques Texeira; André V Gomes; Ricardo Casaroli-Marano; Juliana Maria Ferraz Sallum
Journal:  Genes (Basel)       Date:  2021-05-10       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.